The DOI matches its Crossref record; 131 of the 132 references it cites were found in a registry or an index.
The hypoxic tumour microenvironment and metastatic progression
Abstract
The microenvironment of solid tumours contains regions of poor oxygenation and high acidity. Growing evidence from clinical and experimental studies points to a fundamental role for hypoxia in metastatic progression. Prolonged hypoxia increases genomic instability, genomic heterogeneity, and may act as a selective pressure for tumour cell variants. Hypoxia can also act in an epigenetic fashion, altering the expression of genes. Hypoxia-induced changes in gene expression alter non-specific stress responses, anaerobic metabolism, angiogenesis, tissue remodeling, and cell-cell contacts. Experimental studies have demonstrated that inhibition of proteins involved in these processes can modify metastasis formation, suggesting a causal role in metastatic progression. Recent advances in high-throughput screening techniques have allowed identification of many hypoxia-induced genes that are involved in the processes associated with metastasis. Here we review the epigenetic control of gene expression by the hypoxic microenvironment and its potential contribution to metastatic progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Exposing cancer cells to hypoxia ex vivo is known to increase lung colonization after intravenous injection [34].”
From The hypoxic tumor microenvironment: A driving force for breast cancer progression (2016) · cites this paper as [34]
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
Disruption of epithelial cell-matrix interactions induces apoptosis
Frisch, S., & Francis, H. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.124.4.619 · Cited by 3,276
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,228
(1999) · PubMed · Cited by 2,204
Interleukin-8 as a macrophage-derived mediator of angiogenesis
Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., & Strieter, R. M. (1992) · Science · doi:10.1126/science.1281554 · Cited by 2,135
Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · PubMed · Cited by 1,727
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558
(2000) · PubMed · Cited by 1,445
Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C., & Semenza, G. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3995-4004.2001 · Cited by 1,256 · cited 1×
“Growth factor stimulation of HIF-1α protein synthesis can also occur, mediated through receptor tyrosine kinase signal transduction converging through the PI3K/PKBAKT pathway [49, 50].”
BackgroundMultistep Nature of Metastatic Inefficiency
Luzzi, K. J., MacDonald, I. C., Schmidt, E. E., Kerkvliet, N. I., Morris, V. L., Chambers, A. F., & Groom, A. C. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65628-3 · Cited by 1,246
(1996) · PubMed · Cited by 1,188
The implications of angiogenesis for the biology and therapy of cancer metastasis
Fidler, I. J. (1994) · Cell · doi:10.1016/0092-8674(94)90187-2 · Cited by 1,099
Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., & Ratcliffe, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8104 · Cited by 1,084
Birchmeier, W., & Behrens, J. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90003-5 · Cited by 1,021
Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5197 · Cited by 1,014 · cited 1×
“Recent studies have shown that hypoxia leads to decreased proteosomal degradation of HIF-1α due to the lack of prolyl hydroxylation of residues within the oxygen-dependent degradation domain, resulting in the inability of VHL to bind [46, 47].”
BackgroundClinical applications of angiogenic growth factors and their inhibitors
Ferrara, N., & Alitalo, K. (1999) · Nature Medicine · doi:10.1038/70928 · Cited by 1,004
The plasminogen activation system in tumor growth, invasion, and metastasis
Andreasen, P. A., Egelund, R., & Petersen, H. H. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050497 · Cited by 947
Nordsmark, M., Overgaard, M., & Overgaard, J. (1996) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(96)91811-3 · Cited by 942
Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology
Semenza, G. L. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02090-1 · Cited by 930
Identifying differences in mRNA expression by representational difference analysis of cDNA
Hubank, M. J. F., & Schatz, D. G. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.25.5640 · Cited by 873
Walenta, S., Wetterling, M., Lehrke, M., Schwickert, G., Sundfør, K., Rofstad, E. K., & Mueller‐Klieser, W. (2000) · PubMed · Cited by 817
Dvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F., & Dvorak, A. M. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59953-8_6 · Cited by 743
Regulation of angiogenesis via vascular endothelial growth factor receptors.
Veikkola, T., Karkkainen, M. J., Claesson, L., & Alitalo, K. K. (2000) · PubMed · Cited by 740
Regulation of Integrin Function by the Urokinase Receptor
Wei, Y., Lukashev, M., Simon, D. I., Bodary, S. C., Rosenberg, S., DOYLE, M. V., & Chapman, H. A. (1996) · Science · doi:10.1126/science.273.5281.1551 · Cited by 727
Al‐Mehdi, A., Tozawa, K., Fisher, A. B., Shientag, L., Lee, A., & Muschel, R. J. (2000) · Nature Medicine · doi:10.1038/71429 · Cited by 703
The biology of cell locomotion within three-dimensional extracellular matrix
Friedl, P., & Br�cker, E.-B. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050498 · Cited by 651
General mechanisms of metastasis
Woodhouse, E. C., Chuaqui, R. F., & Liotta, L. A. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+ · Cited by 621
Graeber, T. G., Peterson, J., Tsai, M., Monica, K., Fornace, A. J., & Giaccia, A. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.6264 · Cited by 617
(2000) · PubMed · Cited by 614
(2001) · PubMed · Cited by 605
Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome
Brizel, D. M., Dodge, R. K., Clough, R. W., & Dewhirst, M. W. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00102-4 · Cited by 548
Loncaster, J. A., Harris, A. L., Davidson, S. E., Logue, J. P., Hunter, R. D., Wycoff, C. C., Pastorek, J., Ratcliffe, P. J., Stratford, I. J., & West, C. (2001) · PubMed · Cited by 482
Demographic variations in the rising incidence of esophageal adenocarcinoma in white males
Bollschweiler, E., Wolfgarten, E., Gutschow, C. A., & H�lscher, A. H. (2001) · Cancer · doi:10.1002/1097-0142(20010801)92:3 · Cited by 452
Koong, A. C., Chen, E. Y., & Giaccia, A. J. (1994) · PubMed · Cited by 445
23 Genetic instability induced by the tumor microenvironment
Glazer, P. M., Reynolds, T. Y., & Rockwell, S. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)80581-0 · Cited by 429
Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers
Overgaard, J., & Horsman, M. R. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80032-4 · Cited by 420
Agrawal, D. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.7.513 · Cited by 413
IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.
Schadendorf, D., Möller, A., Algermissen, B., Worm, M., Sticherling, M., & Czarnetzki, B. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2667 · Cited by 412
Tumor Hypoxia Has Independent Predictor Impact Only in Patients With Node-Negative Cervix Cancer
Fyles, A., Milosevic, M., Hedley, D., Pintilie, M., Levin, W., Manchul, L., & Hill, R. P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.680 · Cited by 398
Thymidine phosphorylase is angiogenic and promotes tumor growth.
Moghaddam, A., Zhang, H. T., Fan, T., Hu, D. E., Lees, V. C., Turley, H., Fox, S. B., Gatter, K. C., Harris, A. L., & Bicknell, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.998 · Cited by 390
Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells
Young, S. D., Marshall, R. S., & Hill, R. P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9533 · Cited by 381
‘Angioprevention’: angiogenesis is a common and key target for cancer chemopreventive agents
Tosetti, F., Ferrari, N., Flora, S. D., & Albini, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0300rev · Cited by 325
Transcriptional Response to Hypoxia in Human Tumors
Lal, A., Peters, H., Croix, B. S., Haroon, Z. A., Dewhirst, M. W., Strausberg, R. L., Kaanders, J. H. A. M., van der Kogel, A. J., & Riggins, G. J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.17.1337 · Cited by 323
Airley, R. E., Loncaster, J. A., Davidson, S. E., Bromley, M., Roberts, S. K., Patterson, A. V., Hunter, R. D., Stratford, I. J., & West, C. (2001) · PubMed · Cited by 320
(2001) · PubMed · Cited by 292
104 candidate genes for the hypoxic tumor phenotype
Koong, A. C., Denko, N. C., Schindler, C., Le, Q., Terris, D. T., Ibrahim, H. Z., Goffinet, D. R., & Giaccia, A. J. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)90122-0 · Cited by 290
Metastasis-Suppressor Genes: a Review and Perspective on an Emerging Field
Yoshida, B. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.21.1717 · Cited by 273
Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts.
Kallinowski, F., Schlenger, K., Runkel, S., Kloes, M., Stohrer, M., Okunieff, P., & Vaupel, P. W. (1989) · PubMed · Cited by 269
Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.
Watanabe, H., TAKEHANA, K., Date, M., Shinozaki, T., & Raz, A. (1996) · PubMed · Cited by 268
Wykoff, C. C., Pugh, C. W., Maxwell, P. H., Harris, A. L., & Ratcliffe, P. J. (2000) · Oncogene · doi:10.1038/sj.onc.1204012 · Cited by 267
Steps in tumor metastasis: new concepts from intravital videomicroscopy
Chambers, A. F., MacDonald, I. C., Schmidt, E. E., Koop, S., Morris, V. L., Khokha, R., & Groom, A. C. (1995) · Cancer and Metastasis Reviews · doi:10.1007/bf00690599 · Cited by 265
Influence of the hypoxic subvolume on the survival of patients with head and neck cancer
Stadler, P. F., Becker, A., Feldmann, H. J., Hänsgen, G., Dunst, J., Würschmidt, F., & Molls, M. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00115-7 · Cited by 265
Shi, Q., Abbruzzese, J. L., Huang, S., Fidler, I. J., Xiong, Q., & Xie, K. (1999) · PubMed · Cited by 261
Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
Rudland, P. S., Platt-Higgins, A. M., El‐Tanani, M., Rudland, S. D. S., Barraclough, R., Winstanley, J. H. R., Howitt, R., & West, C. R. (2002) · PubMed · Cited by 258
Hypoxia-associated Induction of Early Growth Response-1 Gene Expression
Yan, S.-F., Lu, J., Zou, Y. S., Soh-Won, J., Cohen, D., Buttrick, P. M., Cooper, D. R., Steinberg, S. F., Mackman, N., Pinsky, D. J., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.15030 · Cited by 255
Correlation of high lactate levels in head and neck tumors with incidence of metastasis.
Walenta, S., Salameh, A., Lyng, H., Evensen, J. F., Mitze, M., Rofstad, E. K., & Mueller‐Klieser, W. (1997) · Europe PMC (PubMed Central) · Cited by 251
Beasley, N. J. P., Wykoff, C. C., Watson, P. H., Leek, R., Turley, H., Gatter, K. C., Pastorek, J., Cox, G. J., Ratcliffe, P. J., & Harris, A. L. (2001) · PubMed · Cited by 250
Role of Interleukin-8 in Tumor Growth and Metastasis of Human Melanoma
Bar‐Eli, M. (1999) · Pathobiology · doi:10.1159/000028045 · Cited by 248
Yao, K.-S., Xanthoudakis, S., Curran, T., & O'Dwyer, P. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.5997 · Cited by 241
The integrin-linked kinase (ILK) suppresses anoikis
Attwell, S., Roskelley, C. D., & Dedhar, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203711 · Cited by 239
Rofstad, E. K., & Halsør, E. F. (2000) · PubMed · Cited by 229
Nordsmark, M., Alsner, J., Keller, J. O., Nielsen, O. S., Jensen, O. M., Horsman, M. R., & Overgaard, J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1728 · Cited by 228
Correlation of high lactate levels in human cervical cancer with incidence of metastasis.
Schwickert, G., Walenta, S., Sundfør, K., Rofstad, E. K., & Mueller-Klieser, W. (1995) · PubMed · Cited by 225
Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer.
Inoue, K., Slaton, J. W., Kim, S. J., Perrotte, P., Eve, B. Y., Bar‐Eli, M., Radinsky, R., & Dinney, C. P. (2000) · PubMed · Cited by 222
Scale-Invariant Behavior and Vascular Network Formation in Normal and Tumor Tissue
Gazit, Y., Berk, D. A., Leunig, M., Baxter, L. T., & Jain, R. K. (1995) · Physical Review Letters · doi:10.1103/physrevlett.75.2428 · Cited by 216
Knocke, T.-H., Weitmann, H.-D., Feldmann, H.-J., Selzer, E., & Pötter, R. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00139-5 · Cited by 212
Yamagata, M., Hasuda, K., Stamato, T. D., & Tannock, I. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.289 · Cited by 211
Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer.
Olive, P. L., Aquino‐Parsons, C., MacPhail, S. H., Liao, S. Y., Raleigh, J. A., Lerman, M. I., & Stanbridge, E. J. (2001) · PubMed · Cited by 208
Koukourakis, M. I., Giatromanolaki, A. N., Sivridis, E., Simopoulos, K., Pastorek, J., Wykoff, C. C., Gatter, K. C., & Harris, A. L. (2001) · PubMed · Cited by 200
CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13.
Gao, A. C., Lou, W., Dong, J., & Isaacs, J. T. (1997) · PubMed · Cited by 197
Newell, K. J., Franchi, A. J., Pouysségur, J., & Tannock, I. F. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.1127 · Cited by 196
Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor.
Nam, S. W., Clair, T., Kim, Y. S., McMarlin, A., Schiffmann, E., Liotta, L. A., & Stracke, M. L. (2001) · PubMed · Cited by 195
Rofstad, E. K., Sundfør, K., Lyng, H., & Tropé, C. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1266 · Cited by 194
Physical and Functional Sensitivity of Zinc Finger Transcription Factors to Redox Change
Wu, X., Bishopric, N. H., Discher, D. J., Murphy, B. J., & Webster, K. A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1035 · Cited by 192
Fibroblast growth factors: at the heart of angiogenesis.
Slavin, J. P. (1995) · Cell Biology International · doi:10.1006/cbir.1995.1087 · Cited by 187
Hypoxia Stimulates Urokinase Receptor Expression Through a Heme Protein-Dependent Pathway
Graham, C. H., Fitzpatrick, T. E., & McCrae, K. R. (1998) · Blood · doi:10.1182/blood.v91.9.3300 · Cited by 184
Griffiths, L. A., Dachs, G. U., Bicknell, R., Harris, A. L., & Stratford, I. J. (1997) · PubMed · Cited by 175
Substrate balances across colonic carcinomas in humans.
Holm, E., Hagmüller, E., Staedt, U., Schlickeiser, G., Günther, H.-J., Leweling, H., TOKUS, M., & Kollmar, H. B. (1995) · PubMed · Cited by 168
Discher, D. J., Bishopric, N. H., Wu, X., Peterson, C. A., & Webster, K. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.26087 · Cited by 166
Hypoxia-induced up-regulation of angiogenin in human malignant melanoma.
Hartmann, A., Kunz, M., Köstlin, S., Gillitzer, R., Toksoy, A., Bröcker, E. B., & Klein, C. E. (1999) · PubMed · Cited by 160
Rofstad, E. K., Rasmussen, H., Galappathi, K., Mathiesen, B. S., Nilsen, K., & Graff, B. A. (2002) · PubMed · Cited by 160
Shen, M., Kawamoto, T., Yan, W., Nakamasu, K., Tamagami, M., Koyano, Y., Noshiro, M., & Kato, Y. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6960 · Cited by 155
Concepts of oxygen transport at the microcirculatory level
Dewhirst, M. W. (1998) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(98)80040-4 · Cited by 155
Fink, T., Kazlauskas, A., Poellinger, L., Ebbesen, P., & Zachar, V. (2002) · Blood · doi:10.1182/blood.v99.6.2077 · Cited by 152
Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment.
Denko, N. C., Schindler, C., Koong, A. C., Laderoute, K. R., Green, C., & Giaccia, A. J. (2000) · PubMed · Cited by 148
Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration
Guirguis, R., Margulies, I., Taraboletti, G., Schiffmann, E., & Liotta, L. A. (1987) · Nature · doi:10.1038/329261a0 · Cited by 145
Expression and growth-promoting function of the IL-8 receptor β in human melanoma cells
Norgauer, J., Metzner, B., & Schraufstätter, I. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.3.1132 · Cited by 144
Molecular basis of hypoxia-induced erythropoietin expression
Wang, G. L., & Semenza, G. L. (1996) · Current Opinion in Hematology · doi:10.1097/00062752-199603020-00009 · Cited by 131
Rofstad, E. K., & Danielsen, T. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690586 · Cited by 130
Horsman, M. R. (1995) · Acta Oncologica · doi:10.3109/02841869509094031 · Cited by 126
Hubank, M. J. F., & Schatz, D. G. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)03021-9 · Cited by 125
Young, S. D., & Hill, R. P. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.5.371 · Cited by 125
TURNER, K. J., CREW, J. P., Wykoff, C. C., Watson, P. H., Poulsom, R., Pastorek, J., Ratcliffe, P. J., Cranston, D., & Harris, A. L. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600215 · Cited by 122
White, D. E., Cardiff, R. D., Dedhar, S., & Muller, W. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204910 · Cited by 120
Solórzano, C. C., Baker, C. H., Bruns, C. J., Killion, J. J., Ellis, L. M., Wood, J. M., & Fidler, I. J. (2001) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497801753354267 · Cited by 118
Anoikis and metastatic potential of cloudman S91 melanoma cells.
Zhu, Z., Sanchez-Sweatman, O. H., Huang, X., Wiltrout, R. H., Khokha, R., Zhao, Q., & Gorelik, E. (2001) · PubMed · Cited by 114
Rofstad, E. K., Tunheim, S. H., Mathiesen, B. S., Graff, B. A., Halsør, E. F., Nilsen, K., & Galappathi, K. (2002) · PubMed · Cited by 106
Sundfør, K., Lyng, H., Tropé, C., & Rofstad, E. K. (2000) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00175-9 · Cited by 103
Shi, Q., Le, X., Abbruzzese, J. L., Wang, B., Mujaida, N., Matsushima, K., Huang, S., Xiong, Q., & Xie, K. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099312821 · Cited by 101
Anoxia-Induced Up-Regulation of Interleukin-8 in Human Malignant Melanoma
Kunz, M., Hartmann, A., Flory, E., Toksoy, A., Koczan, D., Thiesen, H., Mukaida, N., Neumann, M., Rapp, U. R., Bröcker, E., et al. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65174-7 · Cited by 98
Relationship of hypoxia to metastatic ability in rodent tumours
Jaeger, K. D., Kavanagh, M.-C., & Hill, R. P. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1743 · Cited by 90
Rudat, V., Vanselow, B., Wollensack, P., Bettscheider, C., Osman-Ahmet, S., Eble, M. J., & Dietz, A. (2000) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(00)00200-0 · Cited by 86
Canning, M. T., Postovit, L.-M. M., Clarke, S. H., & Graham, C. H. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5243 · Cited by 83
Kita, K., Saito, S., Morioka, C. Y., & Watanabe, A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990209)80:4 · Cited by 82
Identification of Genes Differentially Induced by Hypoxia in Pancreatic Cancer Cells
Yoon, D. Y., Büchler, P., Saarikoski, S. T., Hines, O. J., Reber, H. A., & Hankinson, O. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5867 · Cited by 81
Rofstad, E. K., & Halsør, E. F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600052 · Cited by 78
Nuclear Factor Interleukin 6 Motifs Mediate Tissue-specific Gene Transcription in Hypoxia
Yan, S., Zou, Y. S., Mendelsohn, M. M., Gao, Y. J., Naka, Y., Yan, S. D., Pinsky, D. J., & Stern, D. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4287 · Cited by 77
Huang, S., DeGuzman, A., Bucana, C. D., & Fidler, I. J. (2000) · Cytokines Cellular & Molecular Therapy · doi:10.1080/13684730050515868 · Cited by 75
Griffiths, J. R., McIntyre, D. J. O., Howe, F. A., & Stubbs, M. (2001) · Novartis Foundation symposium · doi:10.1002/0470868716.ch4 · Cited by 73
Hasan, N. M., Adams, G., Joiner, M. C., Marshall, J. F., & Hart, I. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.299 · Cited by 70
Jang, A., & Hill, R. P. (1997) · Clinical & Experimental Metastasis · doi:10.1023/a:1018470709523 · Cited by 68
Tumor progression: Potential role of unstable genomic changes
Hill, R. P. (1990) · Cancer and Metastasis Reviews · doi:10.1007/bf00046340 · Cited by 65
Scandurro, A. B., Weldon, C. B., Figueroa, Y., Alam, J., & Beckman, B. S. (2001) · International Journal of Oncology · doi:10.3892/ijo.19.1.129 · Cited by 61
Effect of Hypoxia on Cellular Adhesion to Vitronectin and Fibronectin
Lash, G. E., Fitzpatrick, T. E., & Graham, C. H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5618 · Cited by 44
Grøndahl-Hansen, J., Christensen, I. J., Briand, P., Pappot, H., Mouridsen, H. T., Blichert-Toft, M., Danø, K., & Brünner, N. (1997) · PubMed · Cited by 42
Shen, M., Kawamoto, T., Teramoto, M., Makihira, S., Fujimoto, K., Yan, W., Noshiro, M., & Kato, Y. (2001) · European Journal of Cell Biology · doi:10.1078/0171-9335-00167 · Cited by 42
Maity, A. M., & Solomon, D. (2000) · Experimental Cell Research · doi:10.1006/excr.1999.4804 · Cited by 38
Sandhu, J. K., & Birnboim, H. C. (1997) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(97)00140-1 · Cited by 30
Quality assurance for 3D conformal radiation therapy.
Horsman, M. R., Nordsmark, M., & Overgaard, J. (1998) · PubMed · Cited by 28
Interstitial Fluid Pressure in Cervical Cancer
Milosevic, M., Fyles, A., & Hill, R. P. (2001) · American Journal of Clinical Oncology · doi:10.1097/00000421-200110000-00020 · Cited by 26
Kanayama, H.-O., Yano, S., Kim, S. J., Ozawa, S., Ellis, L. M., & Fidler, I. J. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006792007063 · Cited by 23
Seiki, M., Sato, H., Liotta, L. A., & Schiffmann, E. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490515 · Cited by 17
Expression of Autocrine Motility Factor/Phosphohexose Isomerase in Cos7 Cells
Lagana, A., Duchaîne, T. F., Raz, A., DesGroseillers, L., & Nabi, I. R. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2904 · Cited by 16
Vaage, J. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430530 · Cited by 6
Flagged first, then by citations
1 of the 132 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
McKeown, S. R. (2014) · The British Journal of Radiology · doi:10.1259/bjr.20130676 · Cited by 1,050
Tumor microenvironmental physiology and its implications for radiation oncology
Vaupel, P. W. (2004) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2004.04.008 · Cited by 966
Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia
Liu, J., Bu, W., & Shi, J. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00525 · Cited by 842
Hastings, P. J., Ira, G., & Lupski, J. R. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000327 · Cited by 818
Metadata
- Authors
- Subarsky, P., & Hill, R. P.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Hill, Richard P.
- ORCID
- Hill, Richard P.
- Venue
- Clinical & Experimental Metastasis
- Published
- 2003-05
- Volume
- 20
- Issue
- 3
- Pages
- 237-250
- ISSN
- 0262-0898 (ISSN-L)
- 1573-7276
- OpenAlex
- W122518273
- Cited by
- 327
- References
- 132
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 7 · 2022: 8 · 2021: 12 · 2020: 10 · 2019: 9 · 2018: 4 · 2017: 23 · 2016: 17 · 2015: 12 · 2014: 14 · 2013: 17 · 2012: 9
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Clinical & Experimental Metastasis (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- tumor hypoxia, tumor microenvironment, metastatic progression, genomic instability, genomic heterogeneity, epigenetic regulation, hypoxia-induced gene expression, anaerobic metabolism, angiogenesis, tissue remodeling, cell-cell contact, high-throughput screening, anti-metastatic agents
- MeSH terms
- Animals, Humans, Neoplasm Metastasis, Neoplasm Proteins, Neoplasms, Signal Transduction, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review